2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Beijing Bio-Fortune Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B Patients Human Serum ALbumin/interferon alpha2a, Pegasys - Chronic Hepatitis B | Phase 1 / Phase 2 | Completed | Beijing Bio-Fortune Ltd. | 32 | 2013-11-01 | 2014-11-17 |
| Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase I Study in Chinese Healthy Volunteers Human Serum Albumin/interferon alpha2a 300-1200 mcg single dose S.C., Peginterferon 180 mcg single dose S.C. - Healthy Volunteers | Phase 1 | Completed | Beijing Bio-Fortune Ltd. | 34 | 2013-04-01 | 2014-11-17 |
Interferon alpha-2 (2) · Serum Albumin, Human (2) · peginterferon alfa-2a (1)
China (2)
Junqi Niu, MD (1) · Ning Li, MD (1)